A plenty of distinct mechanisms including PI3K amplification/mutation, PTEN loss of function, Akt overexpression, and S6K1 or eIF4E overexpression can result in the constitutive activation of the PI3K/Akt/mTOR pathway in cancer cells [7]. This evidence concerns the gene MTOR and cancer.